Volume 27, Number 8—August 2021
CME ACTIVITY - Research
Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements
Table 1
Patient no. | Hospital district and case no. | Age, y/sex | Year of fungemia | Medical record of S. cerevisiae var. boulardii probiotic use in previous 3 mo | Days alive after fungemia | Central venous catheter | GI tract disease | Antimicrobial drug before fungemia | Change in medication because of fungemia | Main reason for hospital stay |
---|---|---|---|---|---|---|---|---|---|---|
1 | A1 | 56/M | 2016 | Yes | >90 | No | Duodenal ulcer | Yes | Yes | Antimicrobial drugs and NSAIDs after tooth surgery led to duodenal ulcer and fungemia |
2 | A2 | 42/M | 2013 | No | >90 | No | Achalasia, PEG tube, duodenal ulcer | Yes | Yes | Vomiting, losing weight, duodenal ulcer |
3 | A3 | 42/M | 2010 | No | >90 | No | No | No | Yes | Intravenous drug user who had fungemia |
4 | A4 | 40/M | 2018 | No | >90 | No | No | No | Yes | Methadone substitution therapy for patient who had fever and was feeling ill |
5 | A5 | 77/F | 2011 | Yes | 2 | No | PEG tube | Yes | Yes | Spinocellular carcinoma patient who had problems with PEG tube |
6 | B1 | 67/M | 2009 | Yes | >90 | Yes | Pancreatitis | Yes | Yes | Necrotizing pancreatitis |
7 | B2 | 66/M | 2010 | Yes | 0 | No | PEG tube | Yes | No | PEG tube not in place |
8 | B3 | 52/M | 2012 | NA | >90 | No | No | No | No | HIV positive with illicit drug use in ED and high fever and diarrhea |
9 | B4 | 67/M | 2013 (4 different days) | Yes | 7 | Yes | Chronic pancreatitis with pseudocysts | Yes | Yes | Pseudocyst rupturation into lung |
10 | B5 | 88/M | 2013 | Yes | 19 | NA | Bowel obstruction and diverticulosis | NA | NA | Diarrhea after antimicrobial drug use that later turned into an occlusion |
11 | B6 | 60/M | 2014 | NA | >90 | NA | No | Yes | No | Alcohol abuse, streptococcal septicemia, and bronchopleural fistula |
12 | B7 | 70/F | 2015 | Yes | 14 | No | Local intestinal thickening of unknown reason | Yes | Yes | Unspecified neurologic disease that lead to cachexia |
13 | B8 | 63/M | 2015 | Yes | 26 | No | Stomach cancer | Yes | Yes | Lung abscess treated with lobectomia |
14 | B9 | 91/F | 2015 | Yes | 39 | NA | No | Yes | NA | Varicose ulcer |
15 | B10 | 75/F | 2016 | Yes | >90 | No | Pancreatic cancer | Yes | Yes | Recurrent cholangitis |
16 | B11 | 67/F | 2017 | NA (suspected) | >90 | NA | PEG tube | NA | NA | Multiple sclerosis, PEG tube, diarrhea |
17 | B12 | 55/M | 2018 | Yes | 0 | No | No | Yes | No | Alcohol abuse with delirium and Clostridium difficile diarrhea |
18 | B13 | 86/F | 2018 | Yes | 0 | No | Suspected Crohn disease and diverticulosis | Yes | No | Staphylococcus aureus infection after femoro-popliteal reconstruction |
19 | C1 | 88/F | 2016 | Yes | 0 | No | Colitis ulcerosa | Yes | No | Deep venous thrombosis and fasciotomia |
20 | C2 | 77/M | 2016 | No | 1 | No | No | Yes | No | Alzheimer patient with aspiration pneumonia |
21 | C3 | 85/M | 2016 | NA | 82 | No | Colon carcinoma and biliary duct obstruction | Yes | Yes | Liver abscess and septicemia due to Streptococcus sp., Lactobacillus, sp., use of Rhamnonosus, and Saccharomyces sp. |
22 | C4 | 39/M | 2015 | Yes | >90 | No | Crohn disease | Yes | Yes | Relapse of Crohn disease and spondylitis of cervical spine |
23 | C5 | 80/F | 2012 | Yes | >90 | No | Nasogastric tube | Yes | Yes | Fever, abdominal pain, and vomiting after hip surgery |
24 | C6 | 91/M | 2010 | Yes | 2 | No | No | Yes | No | Severe pneumonia |
25 | D1 | 60/M | 2017 | No | >90 | Yes (PICC) | Bowel obstruction | Yes | Yes | Bowel obstruction due to adhesion |
26 | D2 | 84/M | 2017 | Yes | 1 | No | No | Yes | No | Pneumonia, sepsis, and multiple organ failure |
27 | D3 | 76/F | 2017 | Yes | 0 | Yes | Cholecystitis and bowel ischemia | Yes | No | Bowel ischemia and sepsis |
28 | D4 | 68/M | 2017 | No | >90 | Yes | Esophageal carcinoma | Yes | No | Esophageal carcinoma surgery and diarrhea |
29 | D5 | 80/M | 2017 | NA | NA | NA | NA | NA | NA | Treated in a district hospital |
30 | D6 | 78/F | 2012 | Yes | >90 | Yes | Perforation of sigma | Yes | Yes | Sigma operation and wound infection |
31 | D7 | 39/M | 2014 | No | >90 | No | No | No | Yes | Alcohol abuse in ED with empyema and sepsis |
32 | D8 | 72/F | 2015 | Yes | NA | No | Pancreatic cancer | Yes | Yes | Pancreatic cancer |
33 | D9 | 45/M | 2010 | No | >90 | Yes | Necrotizing pancreatitis | Yes | Yes | Necrotizing pancreatitis with necrosis in multiple other organs |
34 | D10 | 67/F | 2014 | No | >90 | No | No | Yes | Yes | Heart and kidney failure |
35 | D11 | 83/F | 2015 | Yes | NA | Yes | Intestinal perforation | Yes | Yes | Intestinal perforation and abscesses |
36 | D12 | 58/F | 2018 | Yes | >90 | No | Diverticulitis | Yes | Yes | Diverticulitis and intestinal perforation |
37 | E1 | 68/M | 2011 | Yes | >90 | No | No | Yes | Yes | Alcohol abuse and urinary tract infection |
38 | E2 | 83/M | 2013 | NA | 14 | NA | NA | NA | NA | NA |
39 | E3 | 72/F | 2015 | No | 0 | Yes | Prepyloric ulcus | Yes | No | Ulcus, peritonitis, and sepsis |
40 | E4 | 30/F | 2015 | NA | 10 | NA | NA | NA | NA | Treated in a district hospital |
41 | E5 | 52/M | 2015 | Yes | 21 | No | Biliary tract obstruction | Yes | No | Biliary tract obstruction |
42 | E6 | 72/F | 2016 | Yes | >90 | No | Radiation colitis and multiple fistulas | Yes | No | Carcinoma of cervix and fever |
43 | E7 | 39/M | 2016 | No | >90 | No | No | No | No | Intravenous drug user with dyspnea |
44 | E8 | 59/M | NA | NA | NA | NA | NA | NA | NA | Treated in a district hospital |
45 | E9 | 72/M | NA | NA | NA | NA | NA | NA | NA | Treated in a district hospital |
46 | E10 | 93/M | NA | NA | NA | NA | NA | NA | NA | Treated in a district hospital |
*ED, emergency department; GI, gastrointestinal; NA, medical records not available; NSAIDs, nonsteroidal antiinflammatory drugs; PEG, percutaneous endoscopic gastrostomy; PICC, peripherally inserted central catheter.
Page created: May 10, 2021
Page updated: July 14, 2021
Page reviewed: July 14, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.